Last reviewed · How we verify
Erector Spinae Plane Block using 0.2% ropivacaine
Erector Spinae Plane Block using 0.2% ropivacaine is a Small molecule drug developed by Poznan University of Medical Sciences. It is currently FDA-approved.
The Erector Spinae Plane Block using 0.2% ropivacaine, developed by Poznan University of Medical Sciences, is a marketed local anesthetic technique. A key strength is the protection provided by a composition patent expiring in 2028. The primary risk is the lack of revenue data, which may affect investment and market confidence.
At a glance
| Generic name | Erector Spinae Plane Block using 0.2% ropivacaine |
|---|---|
| Sponsor | Poznan University of Medical Sciences |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Erector Spinae Plane Block for Acute Low Back Pain (NA)
- PENG Block vs Suprainguinal FICB vs Lumbar ESPB for Analgesia After Hip Surgery (NA)
- PENG vs L-ESPB With S-ESPB for Analgesia in Total Hip Arthroplasty (PHASE4)
- Local Anesthetic as Single Shot Versus Catheter in Patients Undergoing Video Assisted Thoracoscopic Surgery (PHASE2)
- Perioperative Analgesia With Erector Spinae Plane Block in Liver Transplant Recipients (NA)
- PENG Block vs. ESP Block for Pediatric Hip Surgery (PHASE4)
- Erector Spine Plane (ESP) Block for Analgesia in Pediatric Scoliosis Surgery (NA)
- Ultrasound-guided Erector Spinae Plane Block Using Catheter for Video-assisted Thoracoscopy (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Erector Spinae Plane Block using 0.2% ropivacaine CI brief — competitive landscape report
- Erector Spinae Plane Block using 0.2% ropivacaine updates RSS · CI watch RSS
- Poznan University of Medical Sciences portfolio CI